SCHEMBL7815438

SCHEMBL7815438

CC(C)Oc1ccc(C(C)(C)C)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ CYP3A5 P20815 1/20 0.40
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ BRPF1 P55201 1/20 0.38
▸ SLC7A5 Q01650 2/20 0.37
▸ CPS1 P31327 1/20 0.36
▸ NR1H4 Q96RI1 1/20 0.36
▸ ALDH1A3 P47895 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ TRPV3 Q8NET8 1/20 0.36
▸ KAT6A Q92794 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ PTPN5 P54829 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19154714 0.85 POLB (0.37) ALDH1A1POLBMAPTSLC7A5
SCHEMBL7807878 0.85 POLB (0.42) ALDH1A1CYP3A4CYP3A5POLBMAPT
SCHEMBL30087619 0.80 PARP10 (0.46) ALDH1A1CYP3A4CYP3A5POLBKMT2A
SCHEMBL19422370 0.79 ALDH1A1 (0.42) ALDH1A1POLBMAPTKMT2APARP10
SCHEMBL4640535 0.79 CYP3A4 (0.47) CYP3A4POLBMAPTKMT2ANR1H4
SCHEMBL1506600 0.79 KIF11 (0.49) ALDH1A1KMT2ACPS1
SCHEMBL30628206 0.78 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP3A5POLBKMT2A
SCHEMBL17420711 0.78 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP3A5POLBKMT2A
SCHEMBL18848893 0.78 ALOX5AP (0.40) CYP3A4CYP3A5
SCHEMBL1020456 0.78 ALDH1A1 (0.47) ALDH1A1POLBKMT2APARP10PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2023-11-09 — — US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 — — US disclosed
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. 2022-05-26 — — US disclosed
US-8367838-B2 Amines or amino alcohols as GLYT1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-02-05 — — US disclosed
US-20120232033-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS KOLCZEWSKI SABINE (DE) 2012-09-13 — — US disclosed
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS HOFFMANN-LA ROCHE, INC. 2010-08-19 — — US disclosed
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS HOFFMANN-LA ROCHE, INC. 2010-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALDH1A1 2786/4885CYP3A4 4692/4885CYP3A5 4442/4885
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALDH1A1 2786/4885CYP3A4 4692/4885CYP3A5 4442/4885
US-11685732-B2 MYST family histone acetyltransferase inhibitors EP300, KAT2A, KAT6A ALDH1A1 2786/4885CYP3A4 4692/4885CYP3A5 4442/4885
US-20120232033-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS GFPT1, CEPT1, SLC18A2 ALDH1A1 209/4885CYP3A4 1043/4885CYP3A5 931/4885
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS GFPT1, CEPT1, SLC18A2 ALDH1A1 209/4885CYP3A4 1043/4885CYP3A5 931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback